Molecular function of DR6 for controlling peripheral immunological cells
Project/Area Number |
16K08570
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
General medical chemistry
|
Research Institution | Kitasato University (2019) Asahikawa Medical College (2016-2018) |
Principal Investigator |
|
Project Period (FY) |
2016-04-01 – 2020-03-31
|
Project Status |
Completed (Fiscal Year 2019)
|
Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2018: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2017: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2016: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Keywords | DR6 / SLE / T細胞 / 末梢免疫細胞 / Death Receptor 6 / Syndecan / B細胞 |
Outline of Final Research Achievements |
Activation of peripheral T cells is tightly restricted to prevent induction of auto immunological diseases, such as systemic lupus erythematosus (SLE). Here we report molecular details of an orphan immune regulator, death receptor 6 (DR6/TNFRSF21) in lupus-like disease progression in mice.
|
Academic Significance and Societal Importance of the Research Achievements |
本研究成果により、自己免疫性炎症性疾患の一つである全身性エリテマトーデスのモデルマウス病態発症制御において、DR6分子を介したメカニズムの存在が示唆された。本知見から、DR6分子が上記疾患の治療標的の一つとなりうる可能性が示唆された。
|
Report
(5 results)
Research Products
(11 results)
-
[Journal Article] Inactivated whole virus particle vaccine with potent immunogenicity and limited IL-6 production is ideal for influenza2019
Author(s)
Sekiya T, Mifsud EJ, Ohno M, Nomura N, Sasada M, Fujikura D, Daito T, Shingai M, Ohara Y, Nishimura T, Endo M, Mitsumata R, Ikeda T, Hatanaka H, Kitayama H, Motokawa K, Sobue T, Suzuki S, Itoh Y, Brown LE, Ogasawara K, Kino Y, Kida H
-
Journal Title
Vaccine.
Volume: 37
Pages: 2158-2166
DOI
Related Report
Peer Reviewed / Int'l Joint Research
-
-
-
-
-
-
-
-
-
-